AI is transforming pathology to not only detect and classify cancer but also help predict changes to improve diagnostics.

Every Cure's Grant Mitchell, MD, MBA, explains how perfecting models of human biology with AI may will transform clinical testing of drugs in the future.

How are AI-assisted diagnostics transforming breast tissue analyses? Thomas Fuchs, DrSc, Co-Director of the Hasso Plattner Institute for Digital Health and Dean of Artificial Intelligence and Human Health at the Icahn School of Medicine at Mount Sinai, explains.

How might errors in RNA benefit patients? By providing a road map for immunotherapies. Maria Luisa Pineda, PhD, CEO and Co-Founder of Envisagenics, explains how her company leverages RNA data and AI for immunotherapy development.

Laura Katz, MA, ​founded​ and helms Helaina, a company using its​ proprietary precision ​​fermentation platform to recreate the ​bioactive proteins found in​ human colostrum and​ milk​ to improve health for people of all ages​.

Starting a company out of an academic lab may not be easy, but with the right idea and validated science, investors will come, says UTR Therapeutics CEO Chidiebere Awah, MD.

George Church, PhD, who leads Synthetic Biology at Harvard University's Wyss Institute and has co-founded some 50 biotech companies, shares insights about how machine learning is dramatically transforming the speed of drug development and testing.